| 【Company Research】Baozun (BZUN US) – Reorganizing to capture LT opportunities |
| 【Sector Research】China Internet – February online game market recap |
| 【Company Research】CSPC Pharmaceutical (1093 HK) – mRNA platform verified with product approval |
| 【Company Research】Jiumaojiu (9922 HK) – Post pandemic margin recovery is the key |
| 【Company Research】Tencent (700 HK) – Steady ship and aim for sustainable growth |
| 【Company Research】Xtep (1368 HK) – Excellent YTD performance among all brands |
| 【Company Research】Huya Inc. (HUYA US) – Moving into mild recovery in 2H23E |
| 【Company Research】Hongjiu Fruits (6689 HK) – A solid and robust 2022; all eyes on the upcoming OCF turnaround |
| 【Company Research】WuXi AppTec (603259 CH) – Non-COVID business to maintain solid growth |
| 【Company Research】Kindly Medical (1501 HK) – Rich portfolios guarantee recovery in 2023E |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
